A5025403404- Pneumonia and Respiratory Infections
- Tuberculosis Research and Epidemiology
- Nosocomial Infections in ICU
- Cystic Fibrosis Research Advances
- Mycobacterium research and diagnosis
- Mosquito-borne diseases and control
- Respiratory Support and Mechanisms
- Viral Infections and Vectors
- Infectious Diseases and Tuberculosis
- Antibiotic Resistance in Bacteria
- Respiratory viral infections research
- Pneumocystis jirovecii pneumonia detection and treatment
- Lung Cancer Diagnosis and Treatment
- Pharmacological Effects of Natural Compounds
- Inhalation and Respiratory Drug Delivery
- Enterobacteriaceae and Cronobacter Research
- Viral Infections and Outbreaks Research
- Veterinary medicine and infectious diseases
- COVID-19 Clinical Research Studies
- Hematological disorders and diagnostics
- Antifungal resistance and susceptibility
- Infectious Diseases and Mycology
- Long-Term Effects of COVID-19
- Pleural and Pulmonary Diseases
- Pneumothorax, Barotrauma, Emphysema
Oita University
2020-2024
Beppu Medical Center
2019-2020
National Hospital Organization
2019-2020
University of Brawijaya
2019
National Kinki Chuo Hospital for Chest Disease
2019
Severe fever with thrombocytopenia syndrome (SFTS) is a life-threatening infectious disease for which no effective treatment strategy has been established. Although corticosteroids (CSs) are widely administered to patients SFTS, their efficacy remains uncertain. This study aimed assess the impact of CS therapy on in-hospital mortality SFTS.In this nationwide observational using Japanese Diagnosis Procedure Combination database, hospitalized SFTS from April 2013 March 2021 were reviewed. We...
Although the international guidelines for managing bronchiectasis are centred on preventing exacerbation of bronchiectasis, medical causes admissions to hospital among patients with have not been fully investigated.
Although combination therapy using clarithromycin, rifampicin, and ethambutol is recommended for patients with pulmonary Mycobacterium avium complex (MAC) disease, some do not tolerate it because of adverse effects or underlying diseases. The efficacy safety fluoroquinolone-containing regimens as an alternative remain uncertain. This study aimed to compare the those standard treating MAC disease.We retrospectively included consecutive who were treated in our hospital between January 2011 May...
To the editor,A recent report in present journal focussed on rate and risk factors of recurrent tuberculosis (TB) Yemen, a country where TB is major public health concern [1]. The authors ...
Background: Hemodialysis patients are at high risk for developing Pneumocystis jirovecii pneumonia (PJP), and trimethoprim–sulfamethoxazole (TMP–SMX) is the first-line agent treating this disease. However, there a lack of consensus on required dosage TMP–SMX hemodialysis patients. Methods: This study used nationwide Japanese Diagnosis Procedure Combination database to review hospitalized PJP from April 2014 March 2022. Eligible were divided into high-dose low-dose groups based median daily...
Background: Distinguishing Pseudomonas aeruginosa infection and colonization from respiratory samples is challenging. We aimed to determine useful markers for differentiating P. in community-acquired pneumonia (CAP) patients. Methods: included CAP patients whom was isolated sputum but were not initially treated with aeruginosa-targeting antibiotics. Patients cured antibiotics targeting defined as cases, those unresponsive cases. Results: Of 299 patients, 203 (68%) their initial regimen....
Background/Objectives: Although chronic infection by Pseudomonas aeruginosa among patients with bronchiectasis is associated poor prognosis, the impact of antibiotics P. coverage in who experienced bacterial pneumonia or exacerbation has not been fully investigated. Methods: This study targeted were admitted to hospitals because between April 2018 and March 2020 using a national inpatient database Japan. The association antipseudomonal antibiotic treatment in-hospital mortality was assessed...
Abstract Background Re-expansion pulmonary edema is an uncommon complication following drainage of a pneumothorax or pleural effusion. While noted to complicate COVID-19 patients, no case developing re-expansion has been reported. Case representation A man in his early 40 s without smoking history and underlying diseases suddenly complained left chest pain with dyspnea 1 day after being diagnosed COVID-19. Chest X-ray revealed the lung field, tube was inserted into intrathoracic space...
Although persistent tuberculosis (TB) infection is known to cause calcification in the lungs, relationship between intrathoracic and results of interferon-γ release assay (IGRA) has not been fully elucidated. This study aimed assess association IGRA results. We retrospectively included consecutive patients who concurrently underwent chest X-ray, computed tomography (CT), an IGRA. Patients with a current diagnosis active TB or treatment history latent (LTBI) were excluded. The according X-ray...
Background: Severe fever with thrombocytopenia syndrome (SFTS) is a life-threatening infectious disease for which no effective treatment strategy has been established yet. Although corticosteroids (CSs) are widely administered to patients SFTS, their efficacy remains uncertain. This study aimed assess the impact of CS therapy on mortality SFTS.Methods: In this nationwide observational using Japanese Diagnosis Procedure Combination database, hospitalized SFTS from April 2013 March 2021 were...
however, there was persistence of the symptoms.A repeat chest scan showed interval development cavity formation with no significant change in size mass lesion.The patient referred to thoracic surgery and underwent right lower lobectomy.Intra-operative findings include a well-circumscribed, white, lobulated, solid dense adhesions.There note incomplete major fissure, recurrent posterior branch truncus anterior, early take off middle lobe bronchus.Microscopic examination granuloma budding yeast...
Background: We aimed to compare the rate of severe adverse event (SAE) and treatment outcomes Mycobacterium avium complex lung disease (MAC-LD) patients receiving clarithromycin (CLR) azithromycin (AZM).Methods: Among diagnosed with MAC-LD in 2001-2013, 560 who received at least one dose standard regimen until May 2018 were selected for events analysis.Of them, 316 underwent ≥12 months outcome analysis.The medical records retrospectively reviewed.The SAE success was analysed after...
however, there was persistence of A repeat chest scan showed interval development cavity formation with no significant change in size the mass lesion.The patient referred to thoracic surgery and underwent right lower lobectomy.Intra-operative findings include a well-circumscribed, white, lobulated, solid dense adhesions.There note incomplete major fissure, recurrent posterior branch truncus anterior, early take off middle lobe bronchus.Microscopic examination granuloma budding yeast cells...